剖宫产瘢痕妊娠治疗方式的疗效与安全性:系统评价与网状Meta分析
该系统评价与网状Meta分析纳入73项试验(7项随机对照试验)、共8369例剖宫产瘢痕妊娠患者和17种治疗方式,检索截至2024年1月31日。结果显示腹腔镜、经阴道病灶切除、宫腔镜刮宫及高强度聚焦超声联合吸刮术治愈率较高,子宫动脉化疗栓塞、吸刮术、甲氨蝶呤联合宫腔镜刮宫及全身甲氨蝶呤并发症更易发生。作者认为甲氨蝶呤单独药物治疗不推荐。
要点
- 腹腔镜、经阴道病灶切除、宫腔镜刮宫及高强度聚焦超声联合吸刮术治愈率较高。
- 与吸刮术相比,腹腔镜疗效OR 6.76(95%CI 1.99-23.01),经阴道病灶切除OR 5.92(95%CI 1.47-23.78)。
- 子宫动脉化疗栓塞、吸刮术、甲氨蝶呤联合宫腔镜刮宫及全身甲氨蝶呤并发症更易发生。
核心结论
- 腹腔镜、经阴道病灶切除、宫腔镜刮宫及高强度聚焦超声联合吸刮术疗效更优且并发症减少。
- 甲氨蝶呤(局部引导注射和全身给药)作为单独药物治疗不推荐。
研究设计与样本
- 系统评价与网状Meta分析,检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials从建库至2024年1月31日,并手工检索相关综述和Meta分析。
- 纳入至少10例经超声或磁共振成像诊断为剖宫产瘢痕妊娠的头对头试验,排除Newcastle-Ottawa量表评分<4的低质量试验。
- 共纳入73项试验(7项随机对照试验),评估8369例女性和17种治疗方式;网状Meta分析基于73项报告成功率的试验和55项报告并发症的试验。
主要发现
- 腹腔镜、经阴道病灶切除、宫腔镜刮宫和高强度聚焦超声联合吸刮术的累积排序曲线下面积分别为91.2、88.2、86.9和75.3。
- 与吸刮术相比,疗效OR(95%CI)为:腹腔镜6.76(1.99-23.01),经阴道病灶切除5.92(1.47-23.78),宫腔镜刮宫5.00(1.99-23.78),高强度聚焦超声联合吸刮术3.27(1.08-9.89)。
- 子宫动脉化疗栓塞、吸刮术、甲氨蝶呤联合宫腔镜刮宫和全身甲氨蝶呤治疗后并发症更易发生。
- 有限证据提示宫腔镜刮宫、高强度聚焦超声联合吸刮术和腹腔镜比其他选择更安全;所有数据的置信区间均较宽。
关键数值与推荐
- 推荐腹腔镜、经阴道病灶切除、宫腔镜刮宫及高强度聚焦超声联合吸刮术,因其疗效更优且并发症减少。
- 不推荐甲氨蝶呤(局部引导注射和全身给药)作为单独药物治疗。
临床怎么用
- 临床可考虑将腹腔镜、经阴道病灶切除、宫腔镜刮宫或高强度聚焦超声联合吸刮术作为剖宫产瘢痕妊娠的治疗选择。
- 甲氨蝶呤单独药物治疗不作为推荐。
局限性
- 所有数据的置信区间均较宽。
- 部分安全性比较基于有限证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cesarean scar pregnancy may lead to varying degrees of complications. There are many treatment methods for it, but there are no unified or recognized treatment strategies. This systematic review and network meta-analysis aimed to observe the efficacy and safety of treatment modalities for patients with cesarean scar pregnancy. DATA SOURCES: MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were searched from their inception to January 31, 2024. In addition, relevant reviews and meta-analyses were manually searched for additional references. STUDY ELIGIBILITY CRITERIA: Our study incorporated head-to-head trials involving a minimum of 10 women diagnosed with cesarean scar pregnancy through ultrasound imaging or magnetic resonance imaging, encompassing a detailed depiction of primary interventions and any supplementary measures. Trials with a Newcastle-Ottawa scale score <4 were excluded because of their low quality. METHODS: We conducted a random-effects network meta-analysis and review for cesarean scar pregnancy. Group-level data on treatment efficacy and safety, reproductive outcomes, study design, and demographic characteristics were extracted following a predefined protocol. The quality of studies was assessed using the Cochrane risk-of-bias tools for randomized controlled trials and the Newcastle‒Ottawa scale for cohort studies and case series. The main outcomes were efficacy (initial treatment success) and safety (complications), of which summary odds ratios and the surface under the cumulative ranking curve using pairwise and network meta-analysis with random effects. RESULTS: Seventy-three trials (7 randomized controlled trials) assessing a total of 8369 women and 17 treatment modalities were included. Network meta-analyses were rooted in data from 73 trials that reported success rates and 55 trials that reported complications. The findings indicate that laparoscopy, transvaginal resection, hysteroscopic curettage, and high-intensity focused ultrasound combined with suction curettage demonstrated the highest cure rates, as evidenced by surface under the cumulative ranking curve rankings of 91.2, 88.2, 86.9, and 75.3, respectively. When compared with suction curettage, the odds ratios (95% confidence intervals) for efficacy were as follows: 6.76 (1.99-23.01) for laparoscopy, 5.92 (1.47-23.78) for transvaginal resection, 5.00 (1.99-23.78) for hysteroscopic curettage, and 3.27 (1.08-9.89) for high-intensity focused ultrasound combined with suction curettage. Complications were more likely to occur after receiving uterine artery chemoembolization, suction curettage, methotrexate+hysteroscopic curettage, and systemic methotrexate; hysteroscopic curettage, high-intensity focused ultrasound combined with suction curettage, and Lap were safer than the other options derived from finite evidence; and the confidence intervals of all the data were wide. CONCLUSION: Our findings indicate that laparoscopy, transvaginal resection, hysteroscopic curettage, and high-intensity focused ultrasound combined with suction curettage procedures exhibit superior efficacy with reduced complications. The utilization of methotrexate (both locally guided injection and systemic administration) as a standalone medical treatment is not recommended.
引用
- Fu P, Sun H, Zhang L, et al. Efficacy and safety of treatment modalities for cesarean scar pregnancy: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. 2024. PMID: 38485053. doi:10.1016/j.ajogmf.2024.101328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。